• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Recently Accepted Scientific Publications: NCTR

Publication is an essential component of research. All documents authored by NCTR investigators must undergo the NCTR Document Review and Approval Process, which consists of the review, clearance, and approval by the Center Director prior to submitting the publication to a journal. The lists below identify the NCTR-approved publications that were accepted or published in journals or books.

Red envelope icon for GovdeliveryGet e-mail updates when this information changes.


 Accepted October 2012 — January 2013

  • Chen, H., Chen, D. and Chen, J.J., Assessment of Transferability of Cancer Survival Risk Predictions Across Different Centers, BMC Medical Research Methodology, 13:25:Online: 10.1. (Accepted: 01/13/2013)
     
  • Chen, M., Borlak, J.T. and Tong, W., High Lipophilicity and High Daily Dose of Oral Medications are Associated with Significant Risk for Drug-induced Liver Injury, Hepatology. (Accepted: 11/20/2012)
     
  • Chen, M., Hong, H. and Tong, W., Genomic Biomarkers for Personalized Medicine in Breast Cancer, International Journal of Clinical Pharmacology & Toxicology (IJCPT), 1:302. (Accepted: 11/16/2012)
     
  • Chen, M., Zhang, J., Wang, Y., Liu, Z., Kelly, R., Zhou, G., Fang, H., Borlak, J.T. and Tong, W., Liver Toxicity Knowledge Base (LTKB): A Systems Approach to a Complex Endpoint, Clinical Pharmacology and Toxicology. (Accepted: 1/15/2013)
     
  • Dobrovolsky, V.N., Shaddock, J.G., Mittelstaedt, R.A. and Heflich, R.H., Detection of In Vivo Mutation in the Hprt and Pig-a Genes of Rat Lymphocytes, Molecular Toxicology Protocols. (Accepted: 12/20/2012)
     
  • Foster, L., Allan, M., Khan, A.A., Moore, P., Williams, K.D., Hubbard, M., Dixon, L. and Gurley, B., Multiple Dosing of Ephedra-Free Dietary Supplements: Hemodynamic, Electrocardiographic, and Bacterial Contamination Effects, Clinical Pharmacology & Therapeutics, 93(3):267-274. (Accepted: 12/4/2012)
     
  • Guo, L., Li, Y. and Lin, H., The Expression of Drug-Metabolizing Enzymes and Transporters in Different Hepatic Cells and Human Liver Samples, Introduction to Sequence and Genome Analysis. (Accepted: 12/1/2012)
     
  • Guo, Y., Shi, L., Hong, H., Su, Z., Fuscoe, J. and Ning, B., Studies on Abacavir-Induced Hypersensitivity Reaction: A Successful Example of Translation of Pharmacogenetics to Personalized Medicine, Science China: Life Sciences, 56(2):199-124. (Accepted: 12/22/2012)
     
  • Han, J., Lynne, A.M., David, D.E., Tang, H., Xu, J., Nayak, R.R., Kaldhone, P., Logue, C.M. and Foley, S.L., DNA Sequence Analysis of Plasmids from Multidrug Resistant Salmonella enterica Serotype Heidelberg Isolates, PLoS One, 7(12):1-8. (Accepted: 10/30/2012)
     
  • Hansen, D.K., George, N., White, G.A., Pellicore, L., Abdel-Rahman, A. and Fabricant, D., Effects of Citrus aurantium in Exercised Rats, Cardiovascular Toxicology. (Accepted: 1/24/2013)
     
  • Hong, H., Zhang, W., Shen, J., Su, Z., Ning, B., Han, T., Perkins, R.G., Shi, L. and Tong, W., Critical Role of Bioinformatics in Translating Huge Amounts of Next-Generation Sequencing Data into Personalized Medicine, Science China: Life Science, 56-2:110-118. (Accepted 11/29/2012) 
     
  • Hong, H., Zhang, W., Su, Z., Shen, J., Ge, W., Ning, B., Fang, H., Perkins, R.G., Shi, L. and Tong, W., Next Generation Sequencing: The Revolution in Pharmacogenomics and Personalized Medicine, Pharmacogenomics. (Accepted: 1/17/2013)
     
  • Kim, D., Feng, J., Chen, H., Kweon, O., Gao, Y., Yu, L., Burrowes, V.l. and Sutherland, J.B., Identification of the Enzyme Responsible for N-acetylation of Norfloxacin by Microbacterium sp. strain 4N2-2, Applied and Environmental Microbiology, 79(1):314-321. (Accepted: 10/23/2012) 
     
  • Manjanatha, M., Cao, X., Shelton, S.D., Mittelstaedt, R.A. and Heflich, R.H., In Vivo cII, gtp, and Spi` Gene Mutation Assays in Transgenic Rodents, Humana Press, NY. (Accepted: 12/28/2012)
     
  • Moore, M., Myers, M.B. and Heflich, R.H., Genetic Toxicology, Principles of Toxicology. (Accepted: 1/4/2013)
     
  • Parsons, B.L., Myers, M.B., KRAS Mutant Tumor Subpopulations Can Subvert Durable Responses to Personalized Cancer Treatments, Personalized Medicine, 10(2):191-199. (Accepted: 12/15/2012) 
     
  • Pfuhler, S., Elespuru, R.K., Aardema, M., Doak, S.H., Donner, M., Honma, M., Folders, M.K., Kim, J.H., Landsiedel, R., Manjanatha, M. and Singer, T., Genotoxicity of Nanomaterials: Refining Strategies and Test for Hazard Indentification. Summary of a Workshop of the Environmental Mutagen Society (EMS), Environmental and Molecular Mutagen. (Accepted: 1/24/2013) 
     
  • Rafii, F., Serratia, Encyclopedia of Food Microbiology. (Accepted: 10/15/2012)  
     
  • Schisler, M.R., Moore, M. and Gollapudi, B., In Vitro Mouse Lymphoma (L5178Y Tk+/- 3.7.2.C) Forward Mutation Assay, Protocols in Genotoxicity Assessment. (Accepted: 1/28/2013) 
     
  • Shaheen, B.W., Nayak, R.R., Foley, S.L. and Boothe, D.M., Chromosomal and Plasmid-Mediated Fluoroquinolone Resistance Mechanisms Among Broad-Spectrum-Cephalosporin-Resistant Escherichia coli Isolates Recovered from Companion Animals in the USA, Journal of Anitmicrobial Chemotherapy, 1-6. (Accepted: 12/11/2012) 
     
  • Starlard-Davenport, A., Kutanzi, K.R., Tryndyak, V.P., Word, B.R. and Lyn-Cook, B.A., Restoration of the Methylation Status of Hypermethylated Gene Promoters by miRNA-29B in Human Breast Cancer: A Novel Epigenetic Therapeutic Approach, Carcinogenesis. (Accepted: 12/13/2012) 
     
  • Uehara, T., Kosyk, O., Jeannot, E., Bradford, B.U., Tech, K., Macdonald, J.M., Boorman, G.A., Chatterjee, S., Mason, R.P., Melnyk, S.B., Tryndyak, V.P., Pogribny, I.P. and Rusyn, I., Acetaminophen-Induced Acute Liver Injury in HCV Transgenic Mice, Toxicology and Applied Pharmacology, 15:266(2):224-232. (Accepted: 11/29/2012) 
     
  • Wang, C., Wang, S., Xia, Q., He, W., Yin, J., Fu, P.P. and Li, J., Phototoxicity of Zinc Oxide Nanoparticles in HaCaT Keratinocytes-Generation of Oxidative DNA Damage During UVA and Visible Light Irradiation, Journal of Nanoscience and Nanotechnology. (Accepted: 12/24/2012) 
     
  • Wang, Y., Lin, Z.L., Liu, Z., Harris, S.C., Kelly, R., Chen, M., Borlak, J.T. and Tong, W., A Unifying Ontology to Integrate Histological and Clinical Observations for Drug-Induced Liver Injury, American Journal of Pathology. (Accepted: 12/4/2012) 
     
  • Word, B.R., Lyn-Cook, Jr., L.E., Mwamba, B., Wang, H., Lyn-Cook, B.A. and Hammons, G.J., Cigarette Smoke Condensate (CSC) Induces Differential Expression and Promoter Methylation Profiles of Critical Genes Involved in Lung Cancer in NL-20 Lung Cells In Vitro: Short- term and Chronic Exposure, Open Journal of Cell Biology. Accepted: 10/4/2012) 
     
  • Yang, X., Greenhaw, J., Shi, Q., Roberts, D.W., Hinson, J.A., Muskhelishvili, L., Davis, K.J. and Salminen, W.F., Mouse Liver Protein Sulfhydryl Depletion after Acetaminophen Exposure, Journal of Pharmacology Experimental Therapeutics, Doi:10.1124. (Accepted: 10/23/2012) 
     
  • Yu, L., Phosphopeptide Enrichment Using Offline Titanium Dioxide Columns for Phosphoproteomics, Methods in Molecular Biology. (Accepted: 10/19/2012) 
     
  • Zhang, Y., Ferguson, S.A., Watanabe, F., Xu, Y., Jones, M.Y., Biris, A.S., Hussain, S.M., Howard, P. and Ali, S.F., Effects of Silver Nanoparticles on Body Weight and Locomotor Activity in Male Sprague-Dawley Rats, Small Nano Micro, 9 Issue 4. (Accepted: 1/20/2013)

 

 

Contact FDA

870-543-7000
National Center for Toxicological Research

Food and Drug Administration

3900 NCTR Road

Jefferson, AR 72079
-
-